Amid flurry of new cancer drugs, how many offer real benefits?

CNN Money

9 February 2017 - Marlene McCarthy's breast cancer has grown relentlessly over the past seven years, spreading painfully through her bones and making it impossible to walk without a cane.

Although the 73-year-old knows there's no cure for her disease, she wants researchers to do better. It's been years, she said, since she has found a drug that has actually helped. McCarthy said she's frustrated that the FDA is approving cancer drugs without proof that they cure patients or help them live longer.

"That simply isn't good enough," said McCarthy, of Coventry, R.I. "I understand [why] that could be satisfactory for some people. It isn't to me."

Pushed by patient advocates who want earlier access to medications, the FDA has approved a flurry of oncology drugs in recent years, giving some people with cancer a renewed sense of hope and an array of expensive new options. A few of these drugs have been clear home runs, allowing patients with limited life expectancies to live for years.

Read CNN article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , US